NYSE:DVA DaVita (DVA) Stock Price, News & Analysis $175.53 +5.25 (+3.08%) Closing price 03:59 PM EasternExtended Trading$174.58 -0.96 (-0.54%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About DaVita Stock (NYSE:DVA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get DaVita alerts:Sign Up Key Stats Today's Range$170.00▼$176.4850-Day Range$146.76▼$175.5352-Week Range$105.82▼$176.48Volume639,442 shsAverage Volume537,367 shsMarket Capitalization$14.39 billionP/E Ratio18.94Dividend YieldN/APrice Target$161.80Consensus RatingHold Company OverviewDaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Read More… DaVita Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks78th Percentile Overall ScoreDVA MarketRank™: DaVita scored higher than 78% of companies evaluated by MarketBeat, and ranked 240th out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingDaVita has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 3 hold ratings, and 1 sell rating.Amount of Analyst CoverageDaVita has only been the subject of 1 research reports in the past 90 days.Read more about DaVita's stock forecast and price target. Earnings and Valuation4.4 / 5Proj. Earnings Growth15.76% Earnings GrowthEarnings for DaVita are expected to grow by 15.76% in the coming year, from $9.71 to $11.24 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DaVita is 18.94, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 110.73.Price to Earnings Ratio vs. SectorThe P/E ratio of DaVita is 18.94, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 89.03.Price to Earnings Growth RatioDaVita has a PEG Ratio of 0.82. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioDaVita has a P/B Ratio of 12.88. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about DaVita's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.63% of the float of DaVita has been sold short.Short Interest Ratio / Days to CoverDaVita has a short interest ratio ("days to cover") of 5.8.Change versus previous monthShort interest in DaVita has recently increased by 9.16%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDaVita does not currently pay a dividend.Dividend GrowthDaVita does not have a long track record of dividend growth. Sustainability and ESG4.5 / 5Environmental Score-1.06 Percentage of Shares Shorted5.63% of the float of DaVita has been sold short.Short Interest Ratio / Days to CoverDaVita has a short interest ratio ("days to cover") of 5.8.Change versus previous monthShort interest in DaVita has recently increased by 9.16%, indicating that investor sentiment is decreasing significantly. News and Social Media2.1 / 5News Sentiment0.70 News SentimentDaVita has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for DaVita this week, compared to 9 articles on an average week.Search InterestOnly 7 people have searched for DVA on MarketBeat in the last 30 days. This is a decrease of -30% compared to the previous 30 days.MarketBeat FollowsOnly 13 people have added DaVita to their MarketBeat watchlist in the last 30 days. This is a decrease of -19% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, DaVita insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.00% of the stock of DaVita is held by insiders.Percentage Held by Institutions90.12% of the stock of DaVita is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about DaVita's insider trading history. Receive DVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DaVita and its competitors with MarketBeat's FREE daily newsletter. Email Address DVA Stock News HeadlinesLobbying Update: $1,060,000 of DAVITA INC lobbying was just disclosedJanuary 23, 2025 | nasdaq.comDaVita stock soars to all-time high of $169.54 amid robust growthJanuary 21, 2025 | msn.comVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.January 27, 2025 | Porter & Company (Ad)Brokerages Set DaVita Inc. (NYSE:DVA) Target Price at $161.80January 20, 2025 | americanbankingnews.comDaVita Earnings Preview: What to ExpectJanuary 18, 2025 | msn.comDaVita (NYSE:DVA) Stock Quotes, Forecast and News SummaryJanuary 17, 2025 | benzinga.comIs DaVita Inc. (DVA) the Cheap Value Stock to Invest in According to Warren Buffett?January 16, 2025 | msn.comDaVita Celebrates 25 Years of Exceptional Patient Care, Empowering the Future of Kidney HealthJanuary 15, 2025 | prnewswire.comSee More Headlines DVA Stock Analysis - Frequently Asked Questions How have DVA shares performed this year? DaVita's stock was trading at $149.55 at the beginning of the year. Since then, DVA stock has increased by 17.4% and is now trading at $175.53. View the best growth stocks for 2025 here. How were DaVita's earnings last quarter? DaVita Inc. (NYSE:DVA) released its earnings results on Tuesday, October, 29th. The company reported $2.59 EPS for the quarter, missing analysts' consensus estimates of $2.76 by $0.17. The company's revenue for the quarter was up 4.6% on a year-over-year basis. Read the conference call transcript. Does DaVita have any subsidiaries? The following companies are subsidiaries of DaVita: Northwest Physicians Network, Purity Dialysis, Family Health Care of Central Florida, Healthcare Partners, Gambro Healthcare, Aberdeen Dialysis LLC, Accountable Kidney Care LLC, and more. Who are DaVita's major shareholders? DaVita's top institutional shareholders include KBC Group NV (0.39%), Nordea Investment Management AB (0.32%), Wedge Capital Management L L P NC (0.27%) and abrdn plc (0.22%). Insiders that own company stock include Javier Rodriguez, Michael David Staffieri, Joel Ackerman, Kathleen Alyce Waters, James O Hearty, Charles Berg, John M Nehra, Phyllis R Yale, Barbara J Desoer and Paula A Price. View institutional ownership trends. How do I buy shares of DaVita? Shares of DVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of DaVita own? Based on aggregate information from My MarketBeat watchlists, some other companies that DaVita investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), TotalEnergies (TTE) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings10/29/2024Today1/27/2025Next Earnings (Estimated)2/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryHealth Care Services Current SymbolNYSE:DVA CUSIP23918K10 CIK927066 Webwww.davita.com Phone(720) 631-2100Fax302-636-5454Employees70,000Year Founded1999Price Target and Rating Average Stock Price Target$161.80 High Stock Price Target$175.00 Low Stock Price Target$145.00 Potential Upside/Downside-7.9%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$9.27 Trailing P/E Ratio18.94 Forward P/E Ratio18.09 P/E Growth0.82Net Income$691.53 million Net Margins6.53% Pretax Margin11.10% Return on Equity88.18% Return on Assets4.88% Debt Debt-to-Equity Ratio15.78 Current Ratio1.37 Quick Ratio1.33 Sales & Book Value Annual Sales$12.14 billion Price / Sales1.19 Cash Flow$17.53 per share Price / Cash Flow10.02 Book Value$13.63 per share Price / Book12.89Miscellaneous Outstanding Shares82,000,000Free Float80,360,000Market Cap$14.40 billion OptionableOptionable Beta0.92 Social Links 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NYSE:DVA) was last updated on 1/27/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DaVita Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DaVita With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.